Observational Study Protocol: LIVER-R

Conditions: Hepatobiliary Cancers Interventions: Other: Durvalumab-based combination therapies in observational study setting; Other: Durvalumab-based combination therapies in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials